# ENBREL

NDC: 58406-032
Generic name: etanercept
Labeler / Manufacturer: Immunex Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190607

FDA application: BLA103795

## Active ingredients

- ETANERCEPT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58406-032"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58406-032
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a002b40c-097d-47a5-957f-7a7b1807af7f